Gainers
- ZyVersa Therapeutics ZVSA stock rose 28.8% to $2.1 during Thursday's pre-market session. The market value of their outstanding shares is at $19.3 million.
- SQZ Biotechnologies SQZ shares increased by 25.98% to $0.76. The company's market cap stands at $22.3 million. As per the news, the Q4 earnings report came out yesterday.
- BioSig Technologies BSGM shares increased by 14.4% to $1.35. The market value of their outstanding shares is at $81.7 million.
- Aziyo Biologics AZYO stock moved upwards by 14.28% to $1.36. The company's market cap stands at $21.9 million. As per the news, the Q4 earnings report came out yesterday.
- Generation Bio GBIO shares moved upwards by 13.91% to $4.42. The company's market cap stands at $263.7 million.
- T2 Biosystems TTOO stock rose 10.89% to $0.6. The company's market cap stands at $9.8 million.
Losers
- Strata Skin Sciences SSKN shares declined by 15.5% to $0.87 during Thursday's pre-market session. The company's market cap stands at $30.2 million.
- Context Therapeutics CNTX shares fell 10.61% to $0.59. The market value of their outstanding shares is at $9.4 million. The company's, Q4 earnings came out yesterday.
- Cidara Therapeutics CDTX shares fell 9.74% to $1.72. The market value of their outstanding shares is at $141.8 million. As per the press release, Q4 earnings came out today.
- Science 37 Hldgs SNCE stock decreased by 9.43% to $0.29. The company's market cap stands at $34.4 million.
- Meihua Intl Medical Techs MHUA stock declined by 7.32% to $7.6. The market value of their outstanding shares is at $181.9 million.
- Precigen PGEN shares decreased by 6.94% to $0.94. The company's market cap stands at $237.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in